3Norio Shiraki,Masaki Hara,Hiroyuki Ogino,Yuta Shibamoto,Akihiko Iida,Tsuneo Tamaki,Takayuki Murase,Tadaaki Eimoto.False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET —Radiological-pathological correlation—[J].Annals of Nuclear Medicine.2004(1)
4Khan N,Oriuchi N,Zhang H,Higuchi T,Tian M,Inoue T,et al.A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer[].Nuclear Medicine Communications.2003
5Scanagatta P,Bonadiman C,Falezza G,Terzi A,Magnanelli G,Benato C,et al.Mediastinoscopy for diagnosis of diseases of the chest and staging of lung cancer: our experience in 253 cases[].Chirurgia Italiana.2005
6Spaggiari L,Sverzellati N,Versari A,Paci M,Ferrari G,Nicoli F,et al.Evaluation of N parameter in the staging of non-small cell lung cancer: role of CT and PET[].Radiologia Medica.2005
7Plaisier PW,Mulder HJ,Schouwink JH,de Smit P.Cervical mediastinoscopy in the Netherlands: past or present? A retrospective analysis of 218 procedures[].Netherlands Journal of Medicine.2003
8Aiken NR,Gillies RJ.Phosphomonoester metabolism as a function of cell proliferative status and exogenous precursors[].Anticancer Research.1996
9Vesselle H,Schmidt RA,Pugsley JM,Li M,Kohlmyer SG,Vallires E,et al.Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography[].Clinical Cancer Research.2000
10Larson SM,Nehmeh SA,Erdi YE,Humm JL.PET/CT in non-small-cell lung cancer: value of respiratory-gated PET[].Chang Gung Medical Journal.2005
4Xin-Min D, Qin-Zhi X, Yun-You D, et al. Impact of tracheal mucosa involvement on clinical characteristics of sarcoidosis[J]. South Med J, 2011, 104(5): 315-8.
5Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis [J]. Chest, 2001, 120(3): 881-6.
6Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis[J]. Semin Respir Crit Care Med, 2007, 28(5): 486-95.
7Yasuda S, Shohtsu A, Lde M, et al. High fluorine-18 labeled deoxyglucose uptake in sarcoidosis [J]. Clin Nucl Med, 1996, 21 (12): 983-4.
8Treglia G, Taralli S, Giordano A. Emerging role of whole body f-18-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review [J]. Sarcoidosis Vasculitis Diffuse Lung Dis, 2011, 28(2): 87-94.
9Mostard RL, van Kroonenburgh MJ, Drent M. The role of the PET scan in the management of sarcoidosis [J]. Curr Opin Pulm Med, 2013, 19(5): 538-44.
10Keijsers RG, Verzijlbergen FJ, Oyen WJ, et al. SF-FDG PET, genotype-corrected ACE and slL-2R in newly diagnosed sarcoidosis [J]. Eur J Nucl Med Mol Imaging, 2009, 36(7): 1131-7.
